GODREJAGRO Godrej Agrovet Q3 FY26 results (Oct–Dec 2025) and concall
Godrej Agrovet delivered a strong Q3 performance characterized by disciplined margin expansion and operational efficiencies across most segments. The quarter was highlighted by a sharp turnaround in Astec LifeSciences and record efficiencies in the Vegetable Oil business. While the Dairy segment continues to face headwinds from milk inflation, the company is undergoing a deep strategic portfolio review to prioritize high-growth, high-margin branded retail plays.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q3 FY26: revenue up 10.8%, net profit down 30.1% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 |
|---|---|---|---|---|---|---|
| Revenue | 1,848 | 1,869 | 1,550 | 2,007 | 2,000 +8% | 2,070 +11% |
| EBITDA | 222 | 195 | 130 | 259 | 196 −12% | 212 +9% |
| Net profit | 132 | 166 | 68 | 169 | 177 +34% | 116 −30% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.





